US 9150616
Immunoregulatory peptides and methods of use
granted A61KA61K38/00A61K39/285
Quick answer
US patent 9150616 (Immunoregulatory peptides and methods of use) held by Compass Therapeutics LLC expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K39/285, A61P, A61P1/10